L. Perrigo Company Recalls

All product recalls associated with L. Perrigo Company.

Get alerts for this brand

Recall Summary

Total Recalls

28

Past Year

0

Class I (Serious)

0

Most Recent

Feb 2023

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–20 of 28 recalls

Non-Drowsy Allergy Relief (Perrigo) - Impurity Specifications (2023)

Failed Impurities/Degradation Specifications

Class IIModerate

FDAFeb 9, 2023Nationwide• L. Perrigo Company

Fexofenadine Tablets (Perrigo) – Impurities Spec Failure (2023)

Failed Impurities/Degradation Specifications

Class IIModerate

FDAFeb 9, 2023Nationwide• L. Perrigo Company

Fexofenadine Tablets 180mg (Perrigo) – Impurities Spec Failure (2023)

Failed Impurities/Degradation Specifications

Class IIModerate

FDA

Feb 9, 2023

Nationwide

• L. Perrigo Company

Allergy Relief Tablets (Perrigo) – Impurities Spec Failure (2023)

Failed Impurities/Degradation Specifications

Class IIModerate

FDAFeb 9, 2023Nationwide• L. Perrigo Company

Fexofenadine Tablets (Perrigo) – Impurities Spec Failure (2023)

Failed Impurities/Degradation Specifications

Class IIModerate

FDAFeb 9, 2023Nationwide• L. Perrigo Company

Allergy Relief Tablets (Perrigo) – Impurities Spec Failure (2023)

Failed Impurities/Degradation Specifications

Class IIModerate

FDAFeb 9, 2023Nationwide• L. Perrigo Company

Picnic Allergy Tablets (Perrigo) – Impurities Spec Failure (2023)

Failed Impurities/Degradation Specifications

Class IIModerate

FDAFeb 9, 2023Nationwide• L. Perrigo Company

Allergy Relief Tablets (Perrigo) – Impurities Spec Failure (2023)

Failed Impurities/Degradation Specifications

Class IIModerate

FDAFeb 9, 2023Nationwide• L. Perrigo Company

ALLER-FEX Allergy Tablets (Perrigo) - Impurity Specifications (2023)

Failed Impurities/Degradation Specifications

Class IIModerate

FDAFeb 9, 2023Nationwide• L. Perrigo Company

Allergy Relief Tablets (Perrigo) – Impurities Spec Failure (2023)

Failed Impurities/Degradation Specifications

Class IIModerate

FDAFeb 9, 2023Nationwide• L. Perrigo Company

Fexofenadine Hydrochloride Tablets (Perrigo) - Impurity Specifications (2023)

Failed Impurities/Degradation Specifications

Class IIModerate

FDAFeb 9, 2023Nationwide• L. Perrigo Company

Allergy Relief Tablets (Perrigo) – Impurities Spec Failure (2023)

Failed Impurities/Degradation Specifications

Class IIModerate

FDAFeb 9, 2023Nationwide• L. Perrigo Company

Aller-Ease Allergy Tablets (Perrigo) - Impurity Specifications (2023)

Failed Impurities/Degradation Specifications

Class IIModerate

FDAFeb 9, 2023Nationwide• L. Perrigo Company

Antacid Tablets (Perrigo) – Metal Particle Contamination (2018)

Presence of foreign substance: Product found to contain metal particles.

Class IIModerate

FDANov 6, 2018Nationwide• L. Perrigo Company

Scopolamine Transdermal System (Perrigo) – Defective Delivery (2018)

Defective delivery system

Class IIModerate

FDAMay 11, 2018Nationwide• L. Perrigo Company

Zephrex-D Pseudoephedrine (Perrigo) – microbial contamination (2017)

Microbial Contamination of Non-Sterile Products

Class IIModerate

FDANov 8, 2017Nationwide• L. Perrigo Company

Walgreens Cold & Flu (Perrigo) – Packaging Error (2017)

Labeling: Label Mix-Up - This product is being recalled due to an incorrect product sleeve on the product twin pack. The incorrect product sleeve is for Day-Night Cold and Flu whereas the batch contains Day-Night Cough Liquid.

Class IIILow

FDAJun 5, 2017IL• L. Perrigo Company